Some view the COVID-19 pandemic as a reputational turning point for pharma and an opportunity to solidify a more positive impact on society. Many pharmaceutical companies are furthering this goal by incorporating ESG into their operations.
Today's health businesses face several complex challenges, ranging from stakeholder expectations to regulatory compliance. Amid these, sustainable development often takes a backseat. Sustainability may...